Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11779656 Gene therapy for treating hemophilia A

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
April 13, 2017
Date of Patent
October 10, 2023
Patent Application Number
16093798
Patent Citations
‌
US Patent 7341871 Nucleotide sequences for gene regulation and methods of use thereof
‌
US Patent 7351577 Adeno-associated vector compositions for expression of Factor VIII
‌
US Patent 7351813 Liver-specific gene expression cassettes, and methods of use
‌
US Patent 7572619 Recombinant blood clotting factors
‌
US Patent 7635763 Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use
‌
US Patent 7847088 Classification and diagnosis of the molecular basis of cholestasis
‌
US Patent 7855274 Recombinant factor VIII having increased specific activity
‌
US Patent 7943374 Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb
‌
US Patent 8008468 RNAi expression constructs with liver-specific enhancer/promoter
‌
US Patent 8021875 Methods for expression of transgenes
•••
Patent Inventor Names
James M. Wilson
Lili Wang
Jenny Agnes Sidrane
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11779656
Patent Primary Examiner
‌
Anoop K Singh

Find more entities like US Patent 11779656 Gene therapy for treating hemophilia A

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo